cardioprotective

cardioprotectant

 [kahr″de-o-pro-tek´tant]
1. counteracting cardiotoxic effects.
2. an agent that so acts.

cardioprotective

(kăr″dē-ō-prō-tĕk′tĭv) [Gr. kardia, heart, + L. protectus, shielding]
Capable of shielding the heart from damage caused by, e.g., electrolyte disturbances, infections, ischemia, or toxins.
References in periodicals archive ?
The cardioprotective potential of Coriandrum sativum against salbutamol induced cardiac injury in another experimental model also favored the increased in cardiac markers after administration of two doses of salbutamol (Kousar et al.
A Mediterranean diet rich in virgin olive oil (VOO) could enhance the cardioprotective benefits of HDL ("good") cholesterol, say researchers writing in Circulation, Feb.
The study's big surprise, however, was not empagliflozin's safety, but its striking cardioprotective qualities.
Nuts contain unsaturated fats, highquality protein, vitamins E, folate, and niacin, the minerals magnesium, calcium, and potassium, and phyto-chemicals--plant-based chemicals known to confer cardioprotective benefits and which contain antioxidants, isoflavones, indoles, saponins, and anti-bacterial effects.
To limit the DOX-induced cardiotoxicity, several molecules, such as beta blockers, angiotensin receptor blockers, amifostine, dexrazoxane, Mesna (2-mercaptoethane sulfonate Na), leucovorin, and erythropoietin, have been evaluated as cardioprotective adjuvants in preclinical studies [4].
The first collaborative programme is concentrated on discovering cardioprotective drugs to prevent anthracycline-induced cardiotoxicity.
September 29, 2015 -- Mesoblast Limited (USOTC:MBLTY) said that additional Phase 2 trial results of its lead product candidate for the treatment of chronic heart failure (CHF) showed that its mesenchymal precursor cell (MPC) therapy had the greatest cardioprotective effect in the subset of patients with more advanced heart failure.
September 29, 2015 -- Mesoblast Limited (USOTCMBLTY) said that additional Phase 2 trial results of its lead product candidate for the treatment of chronic heart failure (CHF) showed that its mesenchymal precursor cell (MPC) therapy had the greatest cardioprotective effect in the subset of patients with more advanced heart failure.
These findings add to the other cardioprotective effects that have previously been observed with this diet.